Literature DB >> 33553076

The Oral Microbiome in Pediatric IBD: A Source of Pathobionts or Biomarkers?

Khalid Elmaghrawy1, Séamus Hussey2,3, Gary P Moran1.   

Abstract

The oral cavity is continuous with the gastrointestinal tract and in children, oral health may be closely linked with the overall health of the GI tract. In the case of pediatric Crohn's disease (CD), oral manifestations are an important clinical indicator of intestinal disease. Recent studies of the microbiome in IBD suggest that translocation of oral microbes to the gut may be a common feature of the microbial dysbiosis which is a signature of both CD and ulcerative colitis (UC). Murine studies suggest that translocation of oral bacteria and yeasts to the lower GI tract may trigger inflammation in susceptible hosts, providing a mechanistic link to the development of IBD. Conversely, some studies have shown that dysbiosis of the oral microbiome may occur, possibly as a result of inflammatory responses and could represent a useful source of biomarkers of GI health. This review summarizes our current knowledge of the oral microbiome in IBD and presents current hypotheses on the potential role of this community in the pathogenesis of these diseases.
Copyright © 2021 Elmaghrawy, Hussey and Moran.

Entities:  

Keywords:  Crohn's disease; dysbiosis; inflammation; inflammatory bowel disease; microbiome; oral cavity; ulcerative colitis

Year:  2021        PMID: 33553076      PMCID: PMC7859511          DOI: 10.3389/fped.2020.620254

Source DB:  PubMed          Journal:  Front Pediatr        ISSN: 2296-2360            Impact factor:   3.418


  84 in total

1.  Alterations in diversity of the oral microbiome in pediatric inflammatory bowel disease.

Authors:  Michael J Docktor; Bruce J Paster; Shelly Abramowicz; Jay Ingram; Yaoyu E Wang; Mick Correll; Hongyu Jiang; Sean L Cotton; Alexis S Kokaras; Athos Bousvaros
Journal:  Inflamm Bowel Dis       Date:  2011-10-10       Impact factor: 5.325

2.  Oral manifestations of gastrointestinal diseases in children. Part 2: Crohn's disease.

Authors:  R Crippa; G V Zuccotti; C Mantegazza
Journal:  Eur J Paediatr Dent       Date:  2016-06       Impact factor: 2.231

3.  Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon.

Authors:  P Seksik; L Rigottier-Gois; G Gramet; M Sutren; P Pochart; P Marteau; R Jian; J Doré
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

4.  Redefining the human oral mycobiome with improved practices in amplicon-based taxonomy: discovery of Malassezia as a prominent commensal.

Authors:  Amanda K Dupuy; Marika S David; Lu Li; Thomas N Heider; Jason D Peterson; Elizabeth A Montano; Anna Dongari-Bagtzoglou; Patricia I Diaz; Linda D Strausbaugh
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

5.  Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease.

Authors:  Kelly A Shaw; Madeline Bertha; Tatyana Hofmekler; Pankaj Chopra; Tommi Vatanen; Abhiram Srivatsa; Jarod Prince; Archana Kumar; Cary Sauer; Michael E Zwick; Glen A Satten; Aleksandar D Kostic; Jennifer G Mulle; Ramnik J Xavier; Subra Kugathasan
Journal:  Genome Med       Date:  2016-07-13       Impact factor: 11.117

6.  The gut mycobiome of the Human Microbiome Project healthy cohort.

Authors:  Andrea K Nash; Thomas A Auchtung; Matthew C Wong; Daniel P Smith; Jonathan R Gesell; Matthew C Ross; Christopher J Stewart; Ginger A Metcalf; Donna M Muzny; Richard A Gibbs; Nadim J Ajami; Joseph F Petrosino
Journal:  Microbiome       Date:  2017-11-25       Impact factor: 14.650

7.  Distinct distal gut microbiome diversity and composition in healthy children from Bangladesh and the United States.

Authors:  Audrie Lin; Elisabeth M Bik; Elizabeth K Costello; Les Dethlefsen; Rashidul Haque; David A Relman; Upinder Singh
Journal:  PLoS One       Date:  2013-01-22       Impact factor: 3.240

8.  Oral Manifestations of Crohn's Disease: A Case Report and Review of the Literature.

Authors:  Victoria L Woo
Journal:  Case Rep Dent       Date:  2015-07-09

9.  Fungal microbiota dysbiosis in IBD.

Authors:  Harry Sokol; Valentin Leducq; Hugues Aschard; Hang-Phuong Pham; Sarah Jegou; Cecilia Landman; David Cohen; Giuseppina Liguori; Anne Bourrier; Isabelle Nion-Larmurier; Jacques Cosnes; Philippe Seksik; Philippe Langella; David Skurnik; Mathias L Richard; Laurent Beaugerie
Journal:  Gut       Date:  2016-02-03       Impact factor: 23.059

10.  Dysbiosis and Ecotypes of the Salivary Microbiome Associated With Inflammatory Bowel Diseases and the Assistance in Diagnosis of Diseases Using Oral Bacterial Profiles.

Authors:  Zhe Xun; Qian Zhang; Tao Xu; Ning Chen; Feng Chen
Journal:  Front Microbiol       Date:  2018-05-30       Impact factor: 5.640

View more
  4 in total

1.  Ulcerative Colitis Seems to Imply Oral Microbiome Dysbiosis.

Authors:  Natalia Molinero; Diego Taladrid; Irene Zorraquín-Peña; Miguel de Celis; Ignacio Belda; Alex Mira; Begoña Bartolomé; M Victoria Moreno-Arribas
Journal:  Curr Issues Mol Biol       Date:  2022-03-30       Impact factor: 2.976

2.  Site- and Taxa-Specific Disease-Associated Oral Microbial Structures Distinguish Inflammatory Bowel Diseases.

Authors:  Hari K Somineni; Jordan H Weitzner; Suresh Venkateswaran; Anne Dodd; Jarod Prince; Arjuna Karikaran; Cary G Sauer; Shelly Abramowicz; Michael E Zwick; David J Cutler; David T Okou; Pankaj Chopra; Subra Kugathasan
Journal:  Inflamm Bowel Dis       Date:  2021-11-15       Impact factor: 5.325

3.  The condition of the oral cavity at the time of diagnosis of inflammatory bowel disease in pediatric patients.

Authors:  Małgorzata Klichowska-Palonka; Aneta Komsta; Elżbieta Pac-Kożuchowska
Journal:  Sci Rep       Date:  2021-11-09       Impact factor: 4.379

Review 4.  Armed to the Teeth-The Oral Mucosa Immunity System and Microbiota.

Authors:  Maja Ptasiewicz; Ewelina Grywalska; Paulina Mertowska; Izabela Korona-Głowniak; Agata Poniewierska-Baran; Paulina Niedźwiedzka-Rystwej; Renata Chałas
Journal:  Int J Mol Sci       Date:  2022-01-14       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.